Emanuela Milani-Tschudy
Vice President, Technology DISCO Pharmaceuticals
Seminars
Wednesday 4th February 2026
Protein Nanoscale Organization: Unlocking Surfaceomes to Power Next-Generation Therapeutics
2:00 pm
- Introducing DISCOtech: DISCO's proprietary surfaceome proteomics platform and workflow to systematically map nanoscale organizations on the cell-surface proteins across tumor types
- Demonstrating how DISCOtech reveals tumor-specific vulnerabilities inaccessible through traditional genomics or transcriptomics
- Showcasing the translation from surfaceome discoveries to target candidates into differentiated antibody-based therapeutics with enhanced efficacy and safety profiles
